Lopez-Pais Javier, Izquierdo Coronel Bárbara, Raposeiras-Roubín Sergio, Álvarez Rodriguez Leyre, Vedia Oscar, Almendro-Delia Manuel, Sionis Alessandro, Martin-Garcia Agustin C, Uribarri Aitor, Blanco Emilia, Martín de Miguel Irene, Abu-Assi Emad, Galán Gil David, Sestayo Fernández Manuela, Espinosa Pascual Maria Jesús, Agra-Bermejo Rosa María, López Otero Diego, García Acuña Jose María, Alonso Martín Joaquín Jesús, Gonzalez-Juanatey Jose Ramón, Perez de Juan Romero Miguel Ángel, Núñez-Gil Iván J
Cardiology Department, Complexo Hospitalario Universitario de Ourense, Ourense, Spain.
Cardiology Department, Hospital Universitario de Getafe, Madrid, Spain.
Front Cardiovasc Med. 2022 Mar 14;9:742010. doi: 10.3389/fcvm.2022.742010. eCollection 2022.
Whether Takotsubo syndrome (TTS) should be classified within myocardial infarction with non-obstructive coronary arteries (MINOCAs) is still controversial. The aim of this work was to evaluate the main differences between TTS and non-TTS MINOCAs.
A cohort study based on two prospective registries: TTS from the RETAKO registry (:1,015) and patients with non-TTS MINOCAs from contemporary records of acute myocardial infarction from five 5 national centers (:1,080). Definitions and management recommended by the ESC were used. Survival analysis was based on the Cox regression analysis; propensity score matching (PS) was created to adjust prognostic variables. Takotsubo syndrome were more often women (85.9 vs. 51.9%; < 0.001) and older (69.4 ± 12.5 vs. 64.5 ± 14.1 years; < 0.001). Atrial fibrillation (AF) was more frequent in non-TTS MINOCAs (10.4 vs. 14.4%; = 0.007). Psychiatric disorders were more prevalent in TTS (15.5 vs. 10.2%, < 0.001). In-hospital mortality and complications were higher in TTS: 3.4 vs. 1.8%, ( = 0.015), and 25.8 vs. 11.5%, ( < 0.001). Global mortality before PS matching was 16.1% in non-TTS MINOCAs and 8.1% in TTS. Median follow-up was 32.4 months; after PS matching, TTS had fewer major adverse cardiovascular events (MACEs): hazard ratio (HR) 0.59; 95% CI 0.42-0.83. There were no differences in global mortality (HR 0.87; CI: 0.64-1.19), but TTS had lower cardiovascular mortality (HR 0.58; CI: 0.35-0.98).
Compared to the rest of MINOCAs, TTS presents a different patient profile and a more aggressive acute phase. However, its long-term cardiovascular prognosis is better. These results support that TTS should be considered a separate entity with unique characteristics and prognosis.
应激性心肌病(TTS)是否应归类于非阻塞性冠状动脉心肌梗死(MINOCA)仍存在争议。本研究的目的是评估TTS与非TTS的MINOCA之间的主要差异。
一项基于两个前瞻性注册研究的队列研究:来自RETAKO注册研究的TTS患者(n = 1,015)和来自五个国家中心的当代急性心肌梗死记录中的非TTS的MINOCA患者(n = 1,080)。采用欧洲心脏病学会(ESC)推荐的定义和管理方法。生存分析基于Cox回归分析;创建倾向评分匹配(PS)以调整预后变量。TTS患者女性比例更高(85.9% 对51.9%;P < 0.001)且年龄更大(69.4 ± 12.5岁对64.5 ± 14.1岁;P < 0.001)。非TTS的MINOCA患者心房颤动(AF)更常见(10.4% 对14.4%;P = 0.007)。精神障碍在TTS患者中更普遍(15.5% 对10.2%,P < 0.001)。TTS患者的院内死亡率和并发症更高:分别为3.4% 对1.8%(P = 0.015),以及25.8% 对11.5%(P < 0.001)。在PS匹配前,非TTS的MINOCA患者的总体死亡率为16.1%,TTS患者为8.1%。中位随访时间为32.4个月;PS匹配后,TTS患者的主要不良心血管事件(MACE)较少:风险比(HR)为0.59;95%置信区间(CI)为0.42 - 0.83。总体死亡率无差异(HR 0.87;CI:0.64 - 1.19),但TTS患者的心血管死亡率较低(HR 0.58;CI:0.35 - 0.98)。
与其他MINOCA相比,TTS具有不同的患者特征和更严重的急性期。然而,其长期心血管预后更好。这些结果支持TTS应被视为具有独特特征和预后的独立疾病实体。